Jeff Almeida is a principal at Grant & Eisenhofer practicing in the areas of corporate, securities and consumer litigation.
Mr. Almeida has a wide breadth of complex commercial litigation experience, with over 25 years of litigation experience. He has primarily represented domestic and foreign institutional investors in prominent securities fraud class actions and opt-out cases, including In re JPMorgan Chase & Co. Securities Litigation (London Whale) (S.D.N.Y.); In re Medtronic Securities Litigation (D. Minn.); In re Refco Inc. Securities Litigation (S.D.N.Y.); In re Merck & Co., Inc. Vytorin/Zetia Securities Litigation (D.N.J.); In re Bank of America/Merrill Lynch Securities Litigation (S.D.N.Y.); In re Pfizer Inc. Securities Litigation (S.D.N.Y.); In re Global Cash Access Holdings Securities Litigation (D. Nev.); and In re Career Education Corp. Securities Litigation (S.D. Ill.). In addition, Mr. Almeida has played prominent roles in international securities cases involving RBS (U.K.), Volkswagen (Germany), and Danske Bank (Denmark).
Mr. Almeida has also been actively engaged in derivative, class, and appraisal litigation in the Delaware Court of Chancery, including the matters In re Tyson Foods, Inc. Consolidated Shareholder Litigation, which resulted in historic rulings clarifying the fiduciary duties of corporate directors in connection with the administration of stock option plans; Louisiana Municipal Police Employees’ Retirement System v. Crawford (Caremark), a well-publicized derivative action challenging the terms of the Caremark and CVS merger that resulted in a $3.2 billion settlement; and In re Genentech Inc. Shareholder Litigation, where he successfully represented Genentech minority stockholders in controlling stockholder Roche’s attempt to squeeze out the minority to seize full control of Genentech.
Grant & Eisenhofer currently leverages Mr. Almeida’s broad experience and success in stockholder litigation to manage the firm’s investigation and development of new cases. In this role, Mr. Almeida conducts in-depth investigations into dozens of potential securities fraud claims, and other derivative and corporate governance matters, in order to develop the legal theories that support Grant & Eisenhofer’s litigation efforts.
Prior to joining Grant & Eisenhofer in August 2004, Mr. Almeida was affiliated for six years as an attorney with a major Philadelphia defense firm, where he practiced in the areas of complex commercial litigation and class action defense.
Mr. Almeida is a 1994 graduate of Trinity College in Hartford, Connecticut, where he captained the varsity basketball team and achieved election to Phi Beta Kappa, and a 1997 graduate of William and Mary Law School in Williamsburg, Virginia. Mr. Almeida is admitted to practice in Delaware, Pennsylvania, and New Jersey, along with several federal courts.